Physician profile
Daniel S Sewell
NPI 1609979723
$11,033.44
in general payments reported to CMS, 2019-2025
48 companies · $1,015 in 2025
The $1,015 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,840 · 2020: $1,742 · 2021: $2,069 · 2022: $2,056 · 2023: $1,111 · 2024: $1,201 · 2025: $1,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,327.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,163.71 | 2019-2025 | Linzess, Ubrelvy, Viberzi |
| Novo Nordisk INC | $1,459.49 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $1,176.75 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $485.16 | 2019-2025 | |
| Lilly USA, LLC | $437.22 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Bayer Healthcare Pharmaceuticals INC. | $424.22 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $401.96 | 2019-2022 | |
| Allergan, INC. | $396.80 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $349.08 | 2019-2025 | Breztri, Farxiga |
| Takeda Pharmaceuticals U.S.A., INC. | $297.06 | 2019-2025 | Trintellix |
| Amgen INC. | $281.88 | 2019-2024 | Prolia, Evenity, Repatha |
| Collegium Pharmaceutical, INC. | $259.91 | 2019-2025 | Xtampza |
| Merck Sharp & Dohme LLC | $216.45 | 2019-2022 | |
| Abbott Laboratories | $214.62 | 2021-2025 | Id Now Instrument, Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $213.42 | 2019-2023 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sewell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.